Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PPBT
Stock Latest News
Company Announcements
Purple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform
4d ago
6K
PPBT
Premium
The Fly
Purple Biotech reports IM1240 demonstrates potent anti-tumor activity
4d ago
PPBT
Premium
Company Announcements
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
8d ago
6K
PPBT
Premium
Company Announcements
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
1M ago
6K
PPBT
Premium
The Fly
Purple Biotech announces collaboration with Converge Bio
1M ago
PPBT
Premium
TipRanks Newswire
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
1M ago
CODX
PPBT
Premium
Company Announcements
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns
1M ago
PPBT
Premium
Company Announcements
Purple Biotech Updates March 2026 Corporate Outlook and Pipeline Milestones
1M ago
6K
PPBT
Premium
The Fly
Purple Biotech regains compliance with Nasdaq
1M ago
PPBT
Premium
Company Announcements
Purple Biotech Regains Nasdaq Compliance on Minimum Bid Price
1M ago
6K
PPBT
Premium
The Fly
Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright
2M ago
PPBT
Premium
Company Announcements
Purple Biotech Posts 2025 Loss, Doubles Down on CAPTN-3 Immunotherapy Platform
2M ago
6K
PPBT
Premium
The Fly
Purple Biotech CEO Gil Efron to step down in August
2M ago
PPBT
Premium
The Fly
Purple Biotech reports Q4 EPS ($19.85) vs. ($2.00) last year
2M ago
PPBT
Premium
Market News
Upcoming Stock Splits This Week (March 2 to March 6) – Stay Invested
2M ago
BHLL
BURU
Premium
The Fly
Purple Biotech trading halted, news pending
2M ago
PPBT
Premium
The Fly
Purple Biotech to implement ADS ratio change
2M ago
PPBT
Premium
Company Announcements
Purple Biotech to Implement ADS Ratio Change to Regain Nasdaq Bid-Price Compliance
2M ago
6K
PPBT
Premium
Pre-Earnings
PPBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
PPBT
Premium
Company Announcements
Purple Biotech Unveils January 2026 Corporate Update, Mapping 2026 Catalysts for CAPTN-3 and Oncology Pipeline
4M ago
6K
PPBT
Premium
Company Announcements
Purple Biotech Reports Key Toxicology Milestone for CAPTN-3 Antibody IM1240
4M ago
6K
PPBT
Premium
The Fly
Purple Biotech completes toxicology study of IM1240
4M ago
PPBT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
